3,4,5-Trimethoxyamphetamine
A psychoactive drug of the phenethylamine and amphetamine chemical classes
| 3,4,5-Trimethoxyamphetamine | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | Oral |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | Uncontrolled |
| CAS Number | 2234-16-4 |
| PubChem | 4446 |
| DrugBank | |
| ChemSpider | 4291 |
| KEGG | |
3,4,5-Trimethoxyamphetamine (TMA) is a psychoactive drug of the phenethylamine and amphetamine chemical classes. It is known for its hallucinogenic effects and is structurally related to other psychedelic compounds such as mescaline.
Chemical structure and properties
3,4,5-Trimethoxyamphetamine is a substituted amphetamine, characterized by the presence of three methoxy groups attached to the benzene ring of the amphetamine backbone. The chemical formula is C12H19NO3, and it has a molecular weight of 225.29 g/mol.
Pharmacology
TMA acts primarily as a serotonin receptor agonist, particularly at the 5-HT2A receptor, which is believed to be responsible for its psychedelic effects. The compound also has affinity for other serotonin receptors, contributing to its overall psychoactive profile.
Effects
The effects of 3,4,5-Trimethoxyamphetamine are similar to those of other psychedelic drugs, including altered perception, mood, and cognition. Users may experience visual hallucinations, changes in thought patterns, and an altered sense of time. The intensity and duration of effects can vary based on dosage and individual sensitivity.
History and usage
TMA was first synthesized by the chemist Alexander Shulgin, who documented its effects in his book PiHKAL: A Chemical Love Story. It has been used primarily in research settings to study the effects of psychedelics on the human mind.
Legal status
3,4,5-Trimethoxyamphetamine is not a controlled substance in many countries, but its legal status can vary. It is important to check local regulations before acquiring or using this compound.
Related compounds
See also
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
